![News](https://firebrickpharmabucket.s3.ap-southeast-2.amazonaws.com/wp-content/uploads/2021/11/23084701/hero-banner.jpg)
Archive for October 2022
Nasodine patent granted in Singapore
25 Oct 2022
We are pleased to announce that our patent covering Nasodine ® Nasal Spray1 as a treatment and preventative for the common cold has been granted in Singapore. This brings the number of countries where Firebrick’s core patent has been granted to 27, including: The patent is still pending in Canada and Japan. The pending application…